Table 1.

Study Eligibility Criteria

Study Characteristic	Eligible	Ineligible
Patient population	- Adults (≥18 years) with T2D	- Pediatric (<18 years) people with T2D - People without T2D (eg, T1D, gestational diabetes) - Pregnant women
Intervention	- Pharmacologic treatment for T2D	- Non-pharmacologic treatment for T2D - Treatments for the management of conditions other than T2D
Outcomes	- Adherence - Compliance - Persistence - Discontinuation	- Other outcomes - Adherence/discontinuation measures that were not quantified
Measures of weight change	- Weight - BMI	- Other measures (such as hip-to-waist ratio) - Subjective/perceived weight change - Weight change clearly associated or caused by something other than treatment for T2D (eg, cancer, after weight-loss surgery, post-partum)
Study type	- Real-world cross-sectional study - Real-world case control study - Real-world cohort study - Administrative or claims database study - Real-world EHR - Registry study representing real-world clinical practice - Questionnaires and surveys relating to real-world clinical practice - Clinical trial (Phase III or IV) - Pragmatic trial	- Case studies - Utility studies - Preference or satisfaction studies based on hypothetical profiles - Reviews - Editorials/comments - Economic evaluations - Literature reviews - Clinical trials earlier than Phase III
Language	- English	- Non-English

Abbreviations: BMI, body mass index; EHR, electronic health records; T1D, type 1 diabetes; T2D, type 2 diabetes.